A specific prognosis model for patients with glioma was constructed based on ten hub genes (IL2RB, CD96, CD3D, HOXC9, HOXC5, SLAMF6, GZMH, CD3E, GZMK, and GZMA) (Figures 9H, I). This evidence concerns the gene GZMH and central nervous system cancer.